Similar Efficacy of Ibrutinib Arms across ALPINE and ELEVATE-RR Trials in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison

Shadman, M., Tedeschi, A., Mohseninejad, L., Yang, K., Lamanna, N., Xu, S., Cohen, A. C., Challagulla, S., Xue, M., Williams, R., O’Brien, S. M., Brown, J. R., & Tam, C. S. (2023). Similar Efficacy of Ibrutinib Arms across ALPINE and ELEVATE-RR Trials in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison. Blood, 142(Supplement 1), 4655–4655. https://doi.org/10.1182/blood-2023-179222
Authors:
Mazyar Shadman
Alessandra Tedeschi
Leyla Mohseninejad
Keri Yang
Nicole Lamanna
Sheng Xu
Aileen Cleary Cohen
Swetha Challagulla
Mei Xue
R. Williams
Susan O’Brien
Jennifer R. Brown
Constantine S. Tam
Affiliated Authors:
Nicole Lamanna
Columbia Affiliation:
Subjects:
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2023-179222
DOI:
10.1182/blood-2023-179222
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: